"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
50
SWOG Cancer Research Network
26
Alliance for Clinical Trials in Oncology
17
NRG Oncology
9
ECOG-ACRIN Cancer Research Group
7
Wake Forest University Health Sciences
3
Gynecologic Oncology Group
2
Pfizer
2
Children's Oncology Group
1
Eastern Cooperative Oncology Group
1
NSABP Foundation Inc
1
Clinical Trials at Kaiser Permanente-Modesto
During the past decade, Kaiser Permanente-Modesto conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 40 clinical trials were completed, i.e. on
average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 27 clinical trials were completed. i.e. 192.9%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
2010-03-15
Active, not recruiting
117
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente-Modesto" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 26 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "NRG Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 9 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Modesto"
#1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Kaiser Permanente-Modesto
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Modesto" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (6 trials), "Stage II Breast Cancer" (6 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "Kaiser Permanente-Modesto" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente-Modesto
Most popular intervention types in "Kaiser Permanente-Modesto" are "Drug" (88 trials), "Other" (79 trials), "Biological" (46 trials), "Procedure" (35 trials) and "Radiation" (20 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (36 trials), "Questionnaire Administration" (21 trials), "Nivolumab" (18 trials) and "Biospecimen Collection" (16 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente-Modesto
The vast majority of trials in "Kaiser Permanente-Modesto" are
93 trials for "All" genders, 20 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Kaiser Permanente-Modesto
Currently, there are NaN active trials in "Kaiser Permanente-Modesto".
undefined are not yet recruiting,
30 are recruiting,
61 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Kaiser Permanente-Modesto,
4 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente-Modesto, 3 "Phase 1"
clinical trials were conducted, 46 "Phase 2" clinical
trials and 74 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".